MUB:CA:TSX-Mackenzie Unconstrained Bond ETF (CAD)

ETF | High Yield Fixed Income |

Last Closing

CAD 18.71

Change

+0.01 (+0.03)%

Market Cap

N/A

Volume

7.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for High Yield Fixed Income

Symbol Name Price(Change) Market Cap
ZJK:CA BMO High Yield US Corporate Bo..

-0.04 (-0.22%)

CAD 1.06B
ZHY:CA BMO High Yield US Corporate Bo..

-0.01 (-0.09%)

CAD 0.98B
ZEF:CA BMO Emerging Markets Bond (CAD..

-0.04 (-0.31%)

CAD 0.63B
XHY:CA iShares U.S. High Yield Bond I..

-0.03 (-0.18%)

CAD 0.43B
CVD:CA iShares Convertible Bond Commo..

+0.13 (+0.75%)

CAD 0.10B
SYLD:CA Purpose Strategic Yield Fund E..

+0.05 (+0.26%)

CAD 0.09B
XSI:CA iShares Short Term Strategic F..

+0.01 (+0.06%)

CAD 0.04B
QHY:CA Mackenzie US High Yield Bond I..

N/A

CAD 0.04B
PBD:CA Purpose Total Return Bond

+0.02 (+0.12%)

CAD 0.01B
ZGSB:CA BMO Global Strategic Bond ETF

-0.17 (-0.61%)

CAD 0.01B

ETFs Containing MUB:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (High Yield Fixed Income) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.63% 54% F 26% F
Dividend Return 3.19% 32% F 66% D+
Total Return 5.82% 38% F 32% F
Trailing 12 Months  
Capital Gain 6.85% 21% F 26% F
Dividend Return 5.11% 50% F 76% C+
Total Return 11.96% 38% F 34% F
Trailing 5 Years  
Capital Gain -8.95% 54% F 23% F
Dividend Return 17.45% 59% D- 67% D+
Total Return 8.50% 71% C- 32% F
Average Annual (5 Year Horizon)  
Capital Gain -3.13% N/A N/A 18% F
Dividend Return 0.70% N/A N/A 30% F
Total Return 3.83% N/A N/A 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 4.92% N/A N/A 61% D-
Risk Adjusted Return 14.28% N/A N/A 37% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike